331 related articles for article (PubMed ID: 35567246)
1.
Burlou-Nagy C; Bănică F; Jurca T; Vicaș LG; Marian E; Muresan ME; Bácskay I; Kiss R; Fehér P; Pallag A
Plants (Basel); 2022 May; 11(9):. PubMed ID: 35567246
[No Abstract] [Full Text] [Related]
2. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.
Barnes J; Anderson LA; Gibbons S; Phillipson JD
J Pharm Pharmacol; 2005 Aug; 57(8):929-54. PubMed ID: 16102249
[TBL] [Abstract][Full Text] [Related]
3. The Presence of Molds and Their Secondary Metabolites in Purple Coneflower-Based Dietary Supplements (
Pilarska G; Twarużek M; Ałtyn I
Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136545
[TBL] [Abstract][Full Text] [Related]
4. Active polyphenolic compounds, nutrient contents and antioxidant capacity of extruded fish feed containing purple coneflower (
Oniszczuk T; Oniszczuk A; Gondek E; Guz L; Puk K; Kocira A; Kusz A; Kasprzak K; Wójtowicz A
Saudi J Biol Sci; 2019 Jan; 26(1):24-30. PubMed ID: 30622403
[TBL] [Abstract][Full Text] [Related]
5. Echinacea plants as antioxidant and antibacterial agents: From traditional medicine to biotechnological applications.
Sharifi-Rad M; Mnayer D; Morais-Braga MFB; Carneiro JNP; Bezerra CF; Coutinho HDM; Salehi B; Martorell M; Del Mar Contreras M; Soltani-Nejad A; Uribe YAH; Yousaf Z; Iriti M; Sharifi-Rad J
Phytother Res; 2018 Sep; 32(9):1653-1663. PubMed ID: 29749084
[TBL] [Abstract][Full Text] [Related]
6. Volatile Composition, Antimicrobial Activity, and In Vitro Innate Immunomodulatory Activity of
Dosoky NS; Kirpotina LN; Schepetkin IA; Khlebnikov AI; Lisonbee BL; Black JL; Woolf H; Thurgood TL; Graf BL; Satyal P; Quinn MT
Molecules; 2023 Oct; 28(21):. PubMed ID: 37959750
[No Abstract] [Full Text] [Related]
7. [History of a plant: the example of Echinacea].
Hostettmann K
Forsch Komplementarmed Klass Naturheilkd; 2003 Apr; 10 Suppl 1():9-12. PubMed ID: 12808356
[TBL] [Abstract][Full Text] [Related]
8. Analytical methods for the study of bioactive compounds from medicinally used Echinacea species.
Bruni R; Brighenti V; Caesar LK; Bertelli D; Cech NB; Pellati F
J Pharm Biomed Anal; 2018 Oct; 160():443-477. PubMed ID: 30142565
[TBL] [Abstract][Full Text] [Related]
9. Phytochemical Characterization of Purple Coneflower Roots (
Petrova A; Ognyanov M; Petkova N; Denev P
Molecules; 2023 May; 28(9):. PubMed ID: 37175366
[No Abstract] [Full Text] [Related]
10. First Report of a 16SrII-A Subgroup Phytoplasma Associated with Purple Coneflower (Echinacea purpurea) Witches'-Broom Disease in Taiwan.
Tseng YW; Deng WL; Chang CJ; Su CC; Chen CL; Jan FJ
Plant Dis; 2012 Apr; 96(4):582. PubMed ID: 30727409
[TBL] [Abstract][Full Text] [Related]
11. Studies on phytochemical, antioxidant, anti-inflammatory, hypoglycaemic and antiproliferative activities of Echinacea purpurea and Echinacea angustifolia extracts.
Aarland RC; Bañuelos-Hernández AE; Fragoso-Serrano M; Sierra-Palacios ED; Díaz de León-Sánchez F; Pérez-Flores LJ; Rivera-Cabrera F; Mendoza-Espinoza JA
Pharm Biol; 2017 Dec; 55(1):649-656. PubMed ID: 27951745
[TBL] [Abstract][Full Text] [Related]
12. Sequence characterized amplified region (SCAR) analysis on DNA from the three medicinal Echinacea species.
Adinolfi B; Chicca A; Martinotti E; Breschi MC; Nieri P
Fitoterapia; 2007 Jan; 78(1):43-5. PubMed ID: 17067760
[TBL] [Abstract][Full Text] [Related]
13. Application of HPLC Fingerprint Combined with Chemical Pattern Recognition and Multi-Component Determination in Quality Evaluation of
Lv X; Feng S; Zhang J; Sun S; Geng Y; Yang M; Liu Y; Qin L; Zhao T; Wang C; Liu G; Li F
Molecules; 2022 Sep; 27(19):. PubMed ID: 36235000
[No Abstract] [Full Text] [Related]
14. Genetic characterization of the three medicinal Echinacea species using RAPD analysis.
Nieri P; Adinolfi B; Morelli I; Breschi MC; Simoni G; Martinotti E
Planta Med; 2003 Jul; 69(7):685-6. PubMed ID: 12898432
[TBL] [Abstract][Full Text] [Related]
15. Echinacea purpurea (L.) Moench extract suppresses inflammation by inhibition of C3a/C3aR signaling pathway in TNBS-induced ulcerative colitis rats.
Gu D; Wang H; Yan M; Li Y; Yang S; Shi D; Guo S; Wu L; Liu C
J Ethnopharmacol; 2023 May; 307():116221. PubMed ID: 36754188
[TBL] [Abstract][Full Text] [Related]
16. First Report of Sclerotinia sclerotiorum on Coneflower.
Chang KF; Howard RJ; Gaudiel RG; Hwang SF
Plant Dis; 1997 Sep; 81(9):1093. PubMed ID: 30861967
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines.
Chicca A; Adinolfi B; Martinotti E; Fogli S; Breschi MC; Pellati F; Benvenuti S; Nieri P
J Ethnopharmacol; 2007 Mar; 110(1):148-53. PubMed ID: 17052874
[TBL] [Abstract][Full Text] [Related]
18. Effect of Echinacea purpurea (L.) Moench and its extracts on the immunization outcome of avian influenza vaccine in broilers.
Wang X; Chen J; Chan Y; Li S; Li M; Lin F; Mehmood K; Idrees A; Lin R; Su Y; Wang C; Shi D
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117306. PubMed ID: 37839770
[TBL] [Abstract][Full Text] [Related]
19. Endophytic and rhizospheric bacterial communities isolated from the medicinal plants Echinacea purpurea and Echinacea angustifolia.
Chiellini C; Maida I; Emiliani G; Mengoni A; Mocali S; Fabiani A; Biffi S; Maggini V; Gori L; Vannacci A; Gallo E; Firenzuoli F; Fani R
Int Microbiol; 2014 Sep; 17(3):165-74. PubMed ID: 26419456
[TBL] [Abstract][Full Text] [Related]
20. [Extract of the Echinacea purpurea herb: an allopathic phytoimmunostimulant].
Bauer R; Hoheisel O; Stuhlfauth I; Wolf H
Wien Med Wochenschr; 1999; 149(8-10):185-9. PubMed ID: 10483677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]